EXP WORLD HOLDINGS INC (EXPI)

US30212W1009 - Common Stock

12.84  +0.01 (+0.08%)

After market: 12.84 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to EXPI. EXPI was compared to 68 industry peers in the Real Estate Management & Development industry. While EXPI has a great health rating, there are worries on its profitability. EXPI is not valued too expensively and it also shows a decent growth rate.



2

1. Profitability

1.1 Basic Checks

EXPI had negative earnings in the past year.
In the past year EXPI had a positive cash flow from operations.
In multiple years EXPI reported negative net income over the last 5 years.
In the past 5 years EXPI always reported a positive cash flow from operatings.

1.2 Ratios

EXPI's Return On Assets of -5.06% is in line compared to the rest of the industry. EXPI outperforms 40.30% of its industry peers.
EXPI has a Return On Equity of -10.51%. This is comparable to the rest of the industry: EXPI outperforms 49.25% of its industry peers.
Industry RankSector Rank
ROA -5.06%
ROE -10.51%
ROIC N/A
ROA(3y)7.11%
ROA(5y)4.87%
ROE(3y)13.02%
ROE(5y)8.55%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

EXPI's Gross Margin of 7.45% is on the low side compared to the rest of the industry. EXPI is outperformed by 73.13% of its industry peers.
EXPI's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for EXPI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.17%
GM growth 5Y-1.29%

7

2. Health

2.1 Basic Checks

EXPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
EXPI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, EXPI has more shares outstanding
EXPI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 14.84 indicates that EXPI is not in any danger for bankruptcy at the moment.
EXPI's Altman-Z score of 14.84 is amongst the best of the industry. EXPI outperforms 91.04% of its industry peers.
There is no outstanding debt for EXPI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.84
ROIC/WACCN/A
WACC9.02%

2.3 Liquidity

A Current Ratio of 1.42 indicates that EXPI should not have too much problems paying its short term obligations.
EXPI has a Current ratio (1.42) which is in line with its industry peers.
EXPI has a Quick Ratio of 1.42. This is a normal value and indicates that EXPI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.42, EXPI is in line with its industry, outperforming 55.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42

4

3. Growth

3.1 Past

The earnings per share for EXPI have decreased strongly by -566.67% in the last year.
The Revenue has decreased by -6.90% in the past year.
The Revenue has been growing by 53.64% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-566.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y33.53%
Revenue growth 5Y53.64%
Sales Q2Q%1.37%

3.2 Future

EXPI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 120.15% yearly.
EXPI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.29% yearly.
EPS Next Y83%
EPS Next 2Y141.94%
EPS Next 3Y120.15%
EPS Next 5YN/A
Revenue Next Year5.96%
Revenue Next 2Y6.79%
Revenue Next 3Y5.29%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

EXPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 55.54 indicates a quite expensive valuation of EXPI.
EXPI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXPI is cheaper than 71.64% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of EXPI to the average of the S&P500 Index (23.56), we can say EXPI is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 55.54

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EXPI.
Based on the Price/Free Cash Flow ratio, EXPI is valued cheaper than 92.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.95
EV/EBITDA 176.22

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXPI's earnings are expected to grow with 120.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y141.94%
EPS Next 3Y120.15%

2

5. Dividend

5.1 Amount

EXPI has a Yearly Dividend Yield of 1.47%.
EXPI's Dividend Yield is rather good when compared to the industry average which is at 4.16. EXPI pays more dividend than 88.06% of the companies in the same industry.
EXPI's Dividend Yield is slightly below the S&P500 average, which is at 2.23.
Industry RankSector Rank
Dividend Yield 1.47%

5.2 History

EXPI has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2

5.3 Sustainability

EXPI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-129.98%
EPS Next 2Y141.94%
EPS Next 3Y120.15%

EXP WORLD HOLDINGS INC

NASDAQ:EXPI (11/20/2024, 8:19:44 PM)

After market: 12.84 0 (0%)

12.84

+0.01 (+0.08%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.97B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.47%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 55.54
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.06%
ROE -10.51%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 7.45%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover9.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-566.67%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y83%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y33.53%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y